These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21606247)

  • 21. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.
    Kim DJ; Kim KS; Song MY; Seo SH; Kim SJ; Yang BG; Jang MH; Sung YC
    Clin Immunol; 2012 Sep; 144(3):190-9. PubMed ID: 22836084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response.
    Liu W; Guo W; Guo L; Gu Y; Cai P; Xie N; Yang X; Shu Y; Wu X; Sun Y; Xu Q
    Int Immunopharmacol; 2014 Jun; 20(2):337-45. PubMed ID: 24704625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(+) T cells in mice.
    Boué J; Basso L; Cenac N; Blanpied C; Rolli-Derkinderen M; Neunlist M; Vergnolle N; Dietrich G
    Gastroenterology; 2014 Jan; 146(1):166-75. PubMed ID: 24055279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brazilian propolis ameliorates trinitrobenzene sulfonic acid-induced colitis in mice by inhibiting Th1 differentiation.
    Okamoto Y; Hara T; Ebato T; Fukui T; Masuzawa T
    Int Immunopharmacol; 2013 Jun; 16(2):178-83. PubMed ID: 23602915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis.
    Hainzl E; Stockinger S; Rauch I; Heider S; Berry D; Lassnig C; Schwab C; Rosebrock F; Milinovich G; Schlederer M; Wagner M; Schleper C; Loy A; Urich T; Kenner L; Han X; Decker T; Strobl B; Müller M
    J Immunol; 2015 Nov; 195(10):5011-24. PubMed ID: 26432894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis.
    Bai A; Ma AG; Yong M; Weiss CR; Ma Y; Guan Q; Bernstein CN; Peng Z
    Biochem Pharmacol; 2010 Dec; 80(11):1708-17. PubMed ID: 20797389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic effects of Lonicera japonica extract on dextran sulphate sodium-induced colitis in a mouse model by the inhibition of the Th1/Th17 response.
    Park JW; Bae H; Lee G; Hong BG; Yoo HH; Lim SJ; Lee K; Kim J; Ryu B; Lee BJ; Bae J; Lee H; Bu Y
    Br J Nutr; 2013 Jan; 109(2):283-92. PubMed ID: 22569277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells.
    Sujino T; Kanai T; Ono Y; Mikami Y; Hayashi A; Doi T; Matsuoka K; Hisamatsu T; Takaishi H; Ogata H; Yoshimura A; Littman DR; Hibi T
    Gastroenterology; 2011 Sep; 141(3):1014-23. PubMed ID: 21699791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of Leishmania major in the absence of Tyk2 kinase.
    Schleicher U; Mattner J; Blos M; Schindler H; Röllinghoff M; Karaghiosoff M; Müller M; Werner-Felmayer G; Bogdan C
    Eur J Immunol; 2004 Feb; 34(2):519-29. PubMed ID: 14768057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17-Regulated mRNA Stabilization.
    Muromoto R; Tawa K; Ohgakiuchi Y; Sato A; Saino Y; Hirashima K; Minoguchi H; Kitai Y; Kashiwakura JI; Shimoda K; Oritani K; Matsuda T
    Immunohorizons; 2019 May; 3(5):172-185. PubMed ID: 31356171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis.
    Jiang W; Zhu FG; Bhagat L; Yu D; Tang JX; Kandimalla ER; La Monica N; Agrawal S
    J Invest Dermatol; 2013 Jul; 133(7):1777-84. PubMed ID: 23370539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR-induced cytokines promote effective proinflammatory natural Th17 cell responses.
    Massot B; Michel ML; Diem S; Ohnmacht C; Latour S; Dy M; Eberl G; Leite-de-Moraes MC
    J Immunol; 2014 Jun; 192(12):5635-42. PubMed ID: 24808372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
    Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
    Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses.
    Mori A; Oleszycka E; Sharp FA; Coleman M; Ozasa Y; Singh M; O'Hagan DT; Tajber L; Corrigan OI; McNeela EA; Lavelle EC
    Eur J Immunol; 2012 Oct; 42(10):2709-19. PubMed ID: 22777876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation.
    Hirai T; Kanda T; Sato K; Takaishi M; Nakajima K; Yamamoto M; Kamijima R; Digiovanni J; Sano S
    J Immunol; 2013 May; 190(9):4805-11. PubMed ID: 23543761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.